TRDA
Entrada Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:50 PM EDT
5.37USD-5.458%(-0.31)463,709
Loading…
Loading…
209.67M
Healthcare
Biotechnology
HQ
Boston, MA, USA
130
Previous Close
$5.68
Beta
1.42
52-Week High
$16.45 2026-05-06
52-Week Low
$5.17 2026-10-02
SMA 50
$6.87
SMA 200
$9.33
Avg. Vol 10D
338,662
Avg. Vol 30D
313,071
Avg. Vol 90D
344,598
Relative Vol
1.48
38.94M
22.21M
57.03%
2,744,145
12.36%
8.06
60%/40%
50.37%
33.79%
0.3700%
800,000
279
228
Nov 5, 2026 (31d)
Sep 2, 2026
TRDA Profile
entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
TRDA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.22 | 2026-09-28 | -13.42% | -7.495 |
| 1M | 7.13 | 2026-09-04 | -24.47% | 0.351 |
| 3M | 7.53 | 2026-07-06 | -28.49% | 0.721 |
| 6M | 13.88 | 2026-04-06 | -61.20% | 1.558 |
| 1Y | 6.00 | 2025-10-03 | -10.25% | 1.418 |
| 2Y | 17.07 | 2024-10-04 | -68.45% | — |
| 5Y | 23.95 | 2021-10-29 | -77.52% | 1.076 |
TRDA Stock Summary
Entrada Therapeutics, Inc. Common Stock (NASDAQ:TRDA) stock price today is $5.39, and today's volume is 463,709. TRDA is down 5.194% today. The 30 day average volume is 313,071. TRDA market cap is $209.67M with 38.94M shares outstanding.